ResearcherKyorin UniversityActive in the last 2 years
Ryota Matsuki
Matched on ORCID iD 0000-0002-2438-7698; OpenAlex author ID A5020324270. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 7
- Prognostic impact of imaging tumor regression adjacent to major arteries after preoperative chemotherapy in surgical patients with advanced pancreatic cancer. Co-author DOI 10.1016/j.suronc.2026.102574↗
- Trends in the treatment of advanced pancreatic cancer. Co-author DOI 10.5582/bst.2024.01156↗
- A Prospective Study of Neoadjuvant Gemcitabine Plus Nab-paclitaxel in Patients with Borderline-resectable Pancreatic Cancer. First author DOI 10.2169/internalmedicine.9504-22↗
- Trends in the surgical treatment for pancreatic cancer in the last 30 years. Co-author DOI 10.5582/bst.2022.01250↗
- Trends in the treatment of pancreatic cancer in Japan. Co-author DOI 10.5582/bst.2021.01103↗
- Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal adenocarcinoma: a case report. Co-author DOI 10.1186/s40792-018-0435-2↗
- Asymptomatic Pancreatic Cancer: Does Incidental Detection Impact Long-Term Outcomes? Co-author DOI 10.1007/s11605-017-3421-2↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yoshihiro Sakamoto · 5 shared papers, 2021–2026 · strength 1.02
- Paper Prognostic impact of imaging tumor regression adjacent to major arteries after preoperative chemotherapy in surgical pa… DOI 10.1016/j.suronc.2026.102574↗
- Paper Trends in the treatment of advanced pancreatic cancer. DOI 10.5582/bst.2024.01156↗
- Paper Trends in the treatment of pancreatic cancer in Japan. DOI 10.5582/bst.2021.01103↗
- Hirokazu Momose · 3 shared papers, 2022–2026 · strength 0.69
- Paper Prognostic impact of imaging tumor regression adjacent to major arteries after preoperative chemotherapy in surgical pa… DOI 10.1016/j.suronc.2026.102574↗
- Paper Trends in the treatment of advanced pancreatic cancer. DOI 10.5582/bst.2024.01156↗
- Paper Trends in the surgical treatment for pancreatic cancer in the last 30 years. DOI 10.5582/bst.2022.01250↗
- Naohiro Okano · 3 shared papers, 2022–2026 · strength 0.60
- Paper Prognostic impact of imaging tumor regression adjacent to major arteries after preoperative chemotherapy in surgical pa… DOI 10.1016/j.suronc.2026.102574↗
- Paper A Prospective Study of Neoadjuvant Gemcitabine Plus Nab-paclitaxel in Patients with Borderline-resectable Pancreatic Ca… DOI 10.2169/internalmedicine.9504-22↗
- Paper Trends in the surgical treatment for pancreatic cancer in the last 30 years. DOI 10.5582/bst.2022.01250↗
- Junji Shibahara · 3 shared papers, 2018–2026 · strength 0.54
- Paper Prognostic impact of imaging tumor regression adjacent to major arteries after preoperative chemotherapy in surgical pa… DOI 10.1016/j.suronc.2026.102574↗
- Paper A Prospective Study of Neoadjuvant Gemcitabine Plus Nab-paclitaxel in Patients with Borderline-resectable Pancreatic Ca… DOI 10.2169/internalmedicine.9504-22↗
- Paper Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal adenocarcinoma: a case report. DOI 10.1186/s40792-018-0435-2↗
- Fumio Nagashima · 2 shared papers, 2022–2023 · strength 0.31
- Akimasa Hayashi · 1 shared paper, 2026 · strength 0.29
- Junji Furuse · 2 shared papers, 2018–2023 · strength 0.25
- Paper A Prospective Study of Neoadjuvant Gemcitabine Plus Nab-paclitaxel in Patients with Borderline-resectable Pancreatic Ca… DOI 10.2169/internalmedicine.9504-22↗
- Paper Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal adenocarcinoma: a case report. DOI 10.1186/s40792-018-0435-2↗
- Masanori Sugiyama · 2 shared papers, 2018–2023 · strength 0.25
- Paper A Prospective Study of Neoadjuvant Gemcitabine Plus Nab-paclitaxel in Patients with Borderline-resectable Pancreatic Ca… DOI 10.2169/internalmedicine.9504-22↗
- Paper Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal adenocarcinoma: a case report. DOI 10.1186/s40792-018-0435-2↗
- Shunsuke Watanabe · 1 shared paper, 2023 · strength 0.16
- Yosuke Inoue · 1 shared paper, 2017 · strength 0.06
- Masaru Matsumura · 1 shared paper, 2017 · strength 0.06
- Akio Saiura · 1 shared paper, 2017 · strength 0.06
- Yoshinori Takeda · 1 shared paper, 2017 · strength 0.06
- Takeaki Ishizawa · 1 shared paper, 2017 · strength 0.06
- Masayuki Tanaka · 1 shared paper, 2017 · strength 0.06
- Hiromichi Ito · 1 shared paper, 2017 · strength 0.06
- Yu Takahashi · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.